Clinical Trial Update: Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction [Phase 4]

View source ↗

Summary

Update on a Phase 4 clinical trial evaluating early PCSK9 inhibitor treatment after acute myocardial infarction; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Shanghai Tong Ren Hospital | Conditions: Acute Myocardial Infarction | Phase 4 | Status: RECRUITING